BERNS PAUL L (See Remarks) sold 0.1% of their position (9.82K shares) of NEUMORA THERAPEUTICS, INC. on the open market
Open‑market sale worth $34.5K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/19/2026ACC: 0001610717-26-000052
DirectorOfficer· See Remarks
Since Feb 2026
-9.82K
Net shares
Net seller
$34.5K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
9.82K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−9.82K
Price / share
$3.51
Trade value
$34.46K
% of position
0.1%
2/17/2026
7.41M→7.40M
Total
Net shares
−9.82K
Net value
-$34.46K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/17/2026 | S · Sale | −9.82K | $3.51 | $34.46K | 0.1% | 7.41M | 7.40M |
| Total | −9.82K | -$34.46K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)3
Common Stock
IndirectShares owned133.10K
Common Stock
IndirectShares owned133.10K
Common Stock
IndirectShares owned133.10K
Total
399.29K indirect399.29K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 133.10K | Indirect |
| Common Stock | 133.10K | Indirect |
| Common Stock | 133.10K | Indirect |
| Total | 399.29K | 399.29K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported